Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dame Idossa

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 16, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast CancerAlexis LeVee, Maeve A Hennessy, Dame Idossa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2026
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized ApproachDame Idossa, Maeve A Hennessy, Alexis LeVee, et al.
American Journal of Hematology|August 29, 2018
Mutations and karyotype predict treatment response in myelodysplastic syndromesDame Idossa, Terra L Lasho, Christy M Finke, et al.
Cannabis and Cannabinoid Research|December 30, 2025
A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS)Dylan Zylla, Dame Idossa, Maria Borrero, et al.
JCO Oncology Practice|May 16, 2023
Mentorship Experiences Are Not All the Same: A Survey Study of Oncology Trainees and Early-Career FacultyDame Idossa, Ana I Velazquez, Miki Horiguchi, et al.
American Journal of Hematology|September 7, 2017
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-RAyalew Tefferi, Terra L Lasho, Mrinal M Patnaik, et al.
JCO Oncology Practice|September 14, 2023
Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology SubspecialtiesSindhu Janarthanam Malapati, Dame Idossa, Sunny R K Singh, et al.
Blood Cancer Journal|December 19, 2017
Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)Ayalew Tefferi, Dame Idossa, Terra L Lasho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 2024
Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021Katarina Wang, Alison J Canchola, Meg McKinley, et al.
NPJ Breast Cancer|December 3, 2025
Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancerSaya Jacob, Samantha Fisch, Carolyne Face, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 16, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast CancerAlexis LeVee, Maeve A Hennessy, Dame Idossa, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 24, 2026
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized ApproachDame Idossa, Maeve A Hennessy, Alexis LeVee, et al.
American Journal of Hematology|August 29, 2018
Mutations and karyotype predict treatment response in myelodysplastic syndromesDame Idossa, Terra L Lasho, Christy M Finke, et al.
Cannabis and Cannabinoid Research|December 30, 2025
A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS)Dylan Zylla, Dame Idossa, Maria Borrero, et al.
JCO Oncology Practice|May 16, 2023
Mentorship Experiences Are Not All the Same: A Survey Study of Oncology Trainees and Early-Career FacultyDame Idossa, Ana I Velazquez, Miki Horiguchi, et al.
American Journal of Hematology|September 7, 2017
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-RAyalew Tefferi, Terra L Lasho, Mrinal M Patnaik, et al.
JCO Oncology Practice|September 14, 2023
Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology SubspecialtiesSindhu Janarthanam Malapati, Dame Idossa, Sunny R K Singh, et al.
Blood Cancer Journal|December 19, 2017
Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)Ayalew Tefferi, Dame Idossa, Terra L Lasho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 2024
Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021Katarina Wang, Alison J Canchola, Meg McKinley, et al.
NPJ Breast Cancer|December 3, 2025
Multi-institutional analysis of incidence and risks for late-onset immune toxicity in breast cancerSaya Jacob, Samantha Fisch, Carolyne Face, et al.
Pageof 3